Search research articles
Contact Us
Filters
Showing results (61-70 of 106) with videos related to
Page
of 11
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
April 3, 2017
Use of white matter reference regions for detection of change in florbetapir positron emission tomography from completed phase 3 solanezumab trials
Adam S Fleisher, Abhinay D Joshi, Karen L Sundell, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
March 3, 2018
CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts
Oskar Hansson, John Seibyl, Erik Stomrud, et al.
Synapse (New York, N.Y.)
|
October 9, 2012
Kinetic modeling and occupancy measures of the norepinephrine transporters in baboons using single photon emission computed tomography with (123)I-INER
Adriana Alexandre dos Santos Tavares, Olivier Barret, Jeffery Batis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 14, 2011
SNM practice guideline for dopamine transporter imaging with 123I-ioflupane SPECT 1.0
David S W Djang, Marcel J R Janssen, Nicolaas Bohnen, et al.
Annals of Neurology
|
January 20, 2026
Toward Harmonizing Quantification of Dopamine Neuron Imaging Biomarkers in Parkinson's Disease: The Centamine Scale
Zhen Fan, Graham Searle, Gaia Rizzo, et al.
Clinical and Translational Science
|
February 2, 2019
Molecular Neuroimaging of the Dopamine Transporter as a Patient Enrichment Biomarker for Clinical Trials for Early Parkinson's Disease
Klaus Romero, Daniela Conrado, Jackson Burton, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 13, 2021
Dopamine D<sub>1</sub> Receptor Agonist PET Tracer Development: Assessment in Nonhuman Primates
Olivier Barret, Lei Zhang, David Alagille, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
June 28, 2014
Aβ imaging with 18F-florbetaben in prodromal Alzheimer's disease: a prospective outcome study
Kevin T Ong, Victor L Villemagne, Alex Bahar-Fuchs, et al.
Archives of Neurology
|
April 17, 2008
Serum urate as a predictor of clinical and radiographic progression in Parkinson disease
Michael A Schwarzschild, Steven R Schwid, Kenneth Marek, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
February 12, 2014
A practical approach to remote longitudinal follow-up of Parkinson's disease: the FOUND study
Caroline M Tanner, Cheryl C Meng, Bernard Ravina, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 106) with videos related to
Sort By:
Page
of 11
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
April 3, 2017
Use of white matter reference regions for detection of change in florbetapir positron emission tomography from completed phase 3 solanezumab trials
Adam S Fleisher, Abhinay D Joshi, Karen L Sundell, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
March 3, 2018
CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts
Oskar Hansson, John Seibyl, Erik Stomrud, et al.
Synapse (New York, N.Y.)
|
October 9, 2012
Kinetic modeling and occupancy measures of the norepinephrine transporters in baboons using single photon emission computed tomography with (123)I-INER
Adriana Alexandre dos Santos Tavares, Olivier Barret, Jeffery Batis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 14, 2011
SNM practice guideline for dopamine transporter imaging with 123I-ioflupane SPECT 1.0
David S W Djang, Marcel J R Janssen, Nicolaas Bohnen, et al.
Annals of Neurology
|
January 20, 2026
Toward Harmonizing Quantification of Dopamine Neuron Imaging Biomarkers in Parkinson's Disease: The Centamine Scale
Zhen Fan, Graham Searle, Gaia Rizzo, et al.
Clinical and Translational Science
|
February 2, 2019
Molecular Neuroimaging of the Dopamine Transporter as a Patient Enrichment Biomarker for Clinical Trials for Early Parkinson's Disease
Klaus Romero, Daniela Conrado, Jackson Burton, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 13, 2021
Dopamine D<sub>1</sub> Receptor Agonist PET Tracer Development: Assessment in Nonhuman Primates
Olivier Barret, Lei Zhang, David Alagille, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
June 28, 2014
Aβ imaging with 18F-florbetaben in prodromal Alzheimer's disease: a prospective outcome study
Kevin T Ong, Victor L Villemagne, Alex Bahar-Fuchs, et al.
Archives of Neurology
|
April 17, 2008
Serum urate as a predictor of clinical and radiographic progression in Parkinson disease
Michael A Schwarzschild, Steven R Schwid, Kenneth Marek, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
February 12, 2014
A practical approach to remote longitudinal follow-up of Parkinson's disease: the FOUND study
Caroline M Tanner, Cheryl C Meng, Bernard Ravina, et al.
Page
of 11